Medical College of Wisconsin
CTSICores SearchResearch InformaticsREDCap

Faculty who have authored publication Ruxolitinib for the treatment of steroid-refractory acute GVHD (REACH1): a multicenter, open-label phase 2 trial.

NameTitleDepartmentInstitution
Nirav N. Shah MDAssociate ProfessorMedicineMedical College of Wisconsin